Immunotherapy Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Guidelines in distancing guidelines. We have Fox Team Coverage on the latest response at home and abroad. We begin with Mark Meredith reporting live from the white house. Mark. Reporter good eave nick, jon. The president s advisor are meeting for the Coronavirus Task force, this was a briefing we expected to happen via conference call, now it is happening in the white house situation room. Weve seen a few of the advisors starting to show up. The president as you mentioned tweeted he may or may not do a News Conference out of this. Well be on standby for that. The president told reporters on sa...

Jason Luke, MD, FACP, discusses key takeaways from the KEYNOTE-716 and KEYNOTE-942 trials and other key updates from across the melanoma landscape presented at the 2023 ASCO Annual Meeting.

Spanish researchers at Cima University of Navarra have developed a new immunotherapy combination that improves efficacy in animal models of hepatocellular carcinoma. This is a proof of concept that lays the foundations for the application of this treatment in patients with the most common liver cancer.

Pembrolizumab led to sustained improvements in recurrence-free survival and distant metastasis-free vs placebo as adjuvant therapy in patients with resected stage IIB or IIC melanoma

Jason Luke, MD, FACP, discusses the final analysis of distant metastasis–free survival in the phase 3 KEYNOTE-716 trial of pembrolizumab vs placebo as adjuvant therapy in patients with stage IIB or IIC melanoma.